Guardant Health
279 hedge funds and large institutions have $2.17B invested in Guardant Health in 2023 Q1 according to their latest regulatory filings, with 42 funds opening new positions, 115 increasing their positions, 78 reducing their positions, and 49 closing their positions.
180% more call options, than puts
Call options by funds: $31.8M | Put options by funds: $11.3M
47% more repeat investments, than reductions
Existing positions increased: 115 | Existing positions reduced: 78
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
0.65% less ownership
Funds ownership: 90.67% → 90.02% (-0.65%)
4% less funds holding
Funds holding: 290 → 279 (-11)
14% less capital invested
Capital invested by funds: $2.53B → $2.17B (-$357M)
14% less first-time investments, than exits
New positions opened: 42 | Existing positions closed: 49
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Temasek Holdings
Singapore
|
+$58.4M |
| 2 |
Fidelity International
Hamilton,
Bermuda
|
+$40.7M |
| 3 |
Invesco
Atlanta,
Georgia
|
+$36.7M |
| 4 |
Jacobs Levy Equity Management
Florham Park,
New Jersey
|
+$24.7M |
| 5 |
AllianceBernstein
Nashville,
Tennessee
|
+$22.4M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
-$187M |
| 2 |
Morgan Stanley
New York
|
-$100M |
| 3 |
Viking Global Investors
Stamford,
Connecticut
|
-$44.8M |
| 4 |
VOYA Investment Management
Atlanta,
Georgia
|
-$38M |
| 5 |
Capital Research Global Investors
Los Angeles,
California
|
-$28.6M |
GH Hedge Fund Activity: Q1 2023 in Review
279 of the 6,283 institutional investors tracked by Wall St. Rank reported a position in Guardant Health (GH) for Q1 2023, worth a combined $2.17B — down 14% from $2.53B a quarter earlier.
Sellers outnumbered buyers: 49 funds closed out of GH and 42 opened new positions — a net loss of 7 holders — while 78 trimmed existing stakes and 115 added.
The largest buyer was Temasek Holdings, adding an estimated $58.4M. The largest seller was Fidelity Investments, cutting an estimated $187M.
- 279 institutional investors held Guardant Health (GH) as of Q1 2023, down from 290 in Q4 2022.
- Funds reported $2.17B of Guardant Health stock for Q1 2023, down 14% quarter-over-quarter.
- 42 funds opened new Guardant Health positions in Q1 2023 and 49 closed out, a net change of -7 holders.
- The largest Guardant Health buyer in Q1 2023 was Temasek Holdings, an estimated $58.4M added.
- The largest Guardant Health seller in Q1 2023 was Fidelity Investments, an estimated $187M sold.
Based on aggregated 13F filings for Q1 2023.